Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05681026
Collaborator
National Cancer Institute (NCI) (NIH)
60
1
9
6.6

Study Details

Study Description

Brief Summary

To develop and measure the effects of a culturally sensitive yoga program for inpatients

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Yoga Sessions
  • Behavioral: Questionnaries
  • Behavioral: Interviews

Detailed Description

Primary Objective:
  1. To develop a culturally tailored yoga therapy (YT) program for HSCT patients. We will conduct semi-structured interviews with patients from each center to examine cultural norms, culturally sensitive language, and specific factors relevant to yoga and psychosocial support.
Secondary Objectives:
  1. To optimize the HSCT YT program using an iterative process. Fifteen patients from each center (or until thematic saturation based on exit interviews) will participate in the yoga program throughout the first 30 days of the HSCT. Sessions will be delivered in person, via telehealth (Zoom), or in combination.

  2. To examine feasibility of adherence and follow-up completion. We will declare the intervention feasible if: (a) at least 50% of patients complete a minimum of 50% of the 12 YT sessions, and (b) at least 60% of participants complete follow-up measures at 2 months after transplant (± 7 days).

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Jan 31, 2024
Anticipated Study Completion Date :
Jan 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Yoga Sessions

Participants will take part in Yoga of gentle movements, breathing exercises, relaxation techniques, and meditation all tailored to the participant's needs.

Behavioral: Yoga Sessions
Participants will have up to 12 sessions, 3 sessions per week, over the first 30 days of your hospitalization.

Behavioral: Questionnaries
Participants will complete 4 questionnaires about any symptoms you may be having, any anxiety and/or depression you may be having, your quality of life, and your expectations about your treatment.

Behavioral: Interviews
Participants will have an exit interview last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom, FaceTime, or other approved video call methods.). The interview will be audio and video recorded and transcribed (typed).

Outcome Measures

Primary Outcome Measures

  1. Patient Health Questionnaire-8 (PHQ-8) [through study completion; an average of 1 year]

    The PHQ-8 is a 8-item self-report questionnaire used to assess bother of depressive symptoms over the past 2 weeks. The PHQ-8 is a 8-item questionnaire to screen for degree of depressive symptoms scored on a 0-24 scale with higher scores indicating greater distress and impairment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH;

  2. A minimum of 30-day inpatient hospital stay;

  3. Age 18 or older;

  4. English, Hindi, or Swahili speaking;

  5. Able to sign a written informed consent and be willing to follow protocol requirements.

Exclusion Criteria:
  1. Extreme mobility issues that preclude participating in the YT;

  2. Major thought disorders such as schizophrenia or uncontrolled bipolar disorder;

  3. HCT comorbidity score of 3 or higher

Contacts and Locations

Locations

Site City State Country Postal Code
1 M D Anderson Cancer Center Houston Texas United States 77030

Sponsors and Collaborators

  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Lorenzo Cohen, PHD, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT05681026
Other Study ID Numbers:
  • 2022-0785
  • NCI-2022-10563
  • 3P30CA016672-46S3
First Posted:
Jan 11, 2023
Last Update Posted:
Jan 11, 2023
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 11, 2023